 Current Articles- Lilly's obesity pill Foundayo gains early blockbuster forecast as analysts float 5M+ prescriptions in 2026
2026-04-02 16:05 UTC by Fierce Pharma - Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor
2026-04-02 16:01 UTC by BioSpace - Merit Medical acquires View Point for $140M
2026-04-02 15:58 UTC by Medtech Dive - Approvals in Hand, Lilly and Novo Obesity Pills Will Battle It Out on Hairline Differences
2026-04-02 15:44 UTC by BioSpace - Immunovant’s FcRn inhibitor flunks phase 3 eye disease trials, validating biotech’s waning interest
2026-04-02 15:25 UTC by Fierce Biotech - Data shows 6.7% of global clinical trials impacted by Middle East disruption
2026-04-02 13:35 UTC by Clinical Trials Arena - J&J’s Impella heart pump shows no patient benefit in 2 trials
2026-04-02 13:33 UTC by Medtech Dive - Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
2026-04-02 13:32 UTC by Yahoo/Reuters - Merck KGaA acquires JSR chromatography business
2026-04-02 13:30 UTC by Pharmaceutical Technology - AZ claims another win for Imfinzi in frontline liver cancer
2026-04-02 13:11 UTC by Pharmaphorum - FDA approves Lilly obesity pill, triggering battle with Novo Nordisk
2026-04-02 01:12 UTC by BioPharma Dive - AstraZeneca reports positive data from Phase III trial of efzimfotase alfa
2026-04-02 01:11 UTC by Clinical Trials Arena - Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets
2026-04-02 01:07 UTC by BioPharma Dive - Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
2026-04-02 00:56 UTC by Fierce Biotech - ‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1
2026-04-01 15:54 UTC by Fierce Biotech - Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
2026-04-01 15:53 UTC by BioSpace - Regulatory tracker: Vertex secures broader FDA labels for cystic fibrosis meds Alyftrek, Trikafta
2026-04-01 15:50 UTC by Fierce Pharma - Belgian court orders Poland, Romania to accept $2.2B of Pfizer COVID shots
2026-04-01 15:47 UTC by Seeking Alpha - Novo's Wegovy nets cardio nod from UK cost gatekeeper, adding 1M+ eligible patients
2026-04-01 15:33 UTC by Fierce Pharma - Trump’s MFN pricing expected to delay more European drug launches
2026-04-01 15:10 UTC by BioSpace - Bayer’s head of AI on how to keep up with AI’s radical revolution
2026-04-01 15:00 UTC by Medical Marketing and Media - Telomir seeks FDA approval for Telomir-1 to treat breast cancer
2026-04-01 14:58 UTC by Pharmaceutical Technology - FDA flags serious liver injury cases, 8 deaths with ‘reasonable’ link to Amgen's Tavneos
2026-04-01 14:53 UTC by Fierce Pharma - Whoop raises $575M, adds Abbott as strategic investor
2026-04-01 14:50 UTC by Medtech Dive - Agios mulls early FDA filing for sickle cell therapy
2026-04-01 14:45 UTC by Pharmaphorum - Will Pfizer’s Lyme disease gamble pay off or set the space back?
2026-04-01 14:43 UTC by Pharma Voice - Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
2026-03-31 15:38 UTC by Fierce Biotech - Biogen secures ‘running start’ in kidney disease with $5.6b Apellis buy
2026-03-31 15:36 UTC by BioSpace - Medtronic to study renal denervation combined with PCI
2026-03-31 15:33 UTC by Medtech Dive - Sanofi eczema drug weighed down by mixed results, safety concerns
2026-03-31 15:32 UTC by BioPharma Dive
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |